Rotational Thromboelastometry as a Diagnostic Tool for Persistent Infection in Two-Stage Exchange Arthroplasty

Andreas G Tsantes1,2, Dimitrios V Papadopoulos3, Stavros Goumenos4

  • 1Laboratory of Haematology and Blood Bank Unit, "Attiko" Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.

PubMed

Insights

Rotational thromboelastometry (ROTEM) shows promise in detecting persistent periprosthetic joint infections (PJIs) before reimplantation in two-stage exchange arthroplasty. FIBTEM maximum clot firmness (MCF) demonstrated high accuracy, potentially guiding optimal timing for revision surgery.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Biomarker Discovery
  • Coagulation Analysis

Background:

  • Periprosthetic joint infections (PJIs) pose a significant challenge in orthopedic surgery.
  • Two-stage exchange arthroplasty is a common treatment for chronic PJIs.
  • Reliable biomarkers are lacking to confirm infection eradication before reimplantation.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of rotational thromboelastometry (ROTEM) for persistent infection.
  • To assess ROTEM's utility in guiding reimplantation timing in two-stage exchange arthroplasty for PJI.

Main Methods:

  • Pilot retrospective analysis of 70 patients undergoing two-stage exchange arthroplasty for PJI.
  • Patients categorized based on persistent infection status prior to reimplantation (2018 ICM criteria).
  • Comparison of conventional coagulation biomarkers and ROTEM parameters between groups.

Main Results:

  • Higher FIBTEM maximum clot firmness (MCF) values correlated with persistent infection (OR 1.30).
  • FIBTEM MCF exhibited the highest diagnostic accuracy (AUC 0.907) for persistent infection.
  • A FIBTEM MCF cut-off of ≥ 18 mm showed 100% sensitivity and 73.4% specificity.

Conclusions:

  • ROTEM parameters, particularly FIBTEM MCF, show potential for identifying persistent infections before reimplantation.
  • These coagulation biomarkers may aid in determining the optimal timing for second-stage surgery.
  • Further large-scale studies are needed to validate ROTEM's diagnostic accuracy for persistent PJI.